New drug tested for Tough-to-Treat blood cancer
NCT ID NCT01711632
Summary
This study tested a drug called vemurafenib in 36 adults whose hairy cell leukemia had returned or didn't respond to standard treatments. The main goal was to see how well the drug could eliminate leukemia cells from the blood and how safe it was. Researchers measured the drug's effects over three months and looked for changes in cancer-related proteins.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAIRY CELL LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Northwestern University
Evanston, Illinois, 60208, United States
-
Ohio State University
Columbus, Ohio, 43210, United States
-
Scripps Clinic
La Jolla, California, 92037, United States
Conditions
Explore the condition pages connected to this study.